Authors:
Korting, HC
Tietz, HJ
Brautigam, M
Mayser, P
Rapatz, G
Paul, C
Citation: Hc. Korting et al., One week terbinafine 1% cream (Lamisil (R)) once daily is effective in thetreatment of interdigital tinea pedis: a vehicle controlled study, MED MYCOL, 39(4), 2001, pp. 335-340
Authors:
Konermann, M
Suchantke, R
Mogck, J
Brauburger, J
Brautigam, M
Citation: M. Konermann et al., Formoterol monotherapy compared with combined ipratropium bromide plus fenoterol in the treatment of chronic obstructive pulmonary disease, CLIN DRUG I, 21(4), 2001, pp. 235-242
Authors:
Bunikowski, R
Gerhold, K
Brautigam, M
Hamelmann, E
Renz, H
Wahn, U
Citation: R. Bunikowski et al., Effect of low-dose cyclosporin A microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severepediatric atopic dermatitis, INT A AL IM, 125(4), 2001, pp. 344-348
Authors:
Bunikowski, R
Staab, D
Kussebi, F
Brautigam, M
Weidinger, G
Renz, H
Wahn, U
Citation: R. Bunikowski et al., Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: Clinical and immunological effects, PEDIAT A IM, 12(4), 2001, pp. 216-223
Authors:
Bai, LY
Kon, K
Tatsumi, M
Ito, H
Hayashi, S
Brautigam, M
Citation: Ly. Bai et al., A human B-cell CLL model established by transplantation of JOK-1 cells into SCID mice and an anti-leukemia efficacy of fludarabine phosphate, ONCOL REP, 7(1), 2000, pp. 33-38
Authors:
Czech, W
Brautigam, M
Weidinger, G
Schopf, E
Citation: W. Czech et al., A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life, J AM ACAD D, 42(4), 2000, pp. 653-659
Authors:
Schopf, R
Hettler, O
Brautigam, M
Weidinger, G
Kaben, U
Mayser, P
Resl, V
Citation: R. Schopf et al., Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial, MYCOSES, 42(5-6), 1999, pp. 415-420
Authors:
Yabuuchi, F
Takahashi, M
Aritake, K
Fujimoto, M
Ito, H
Tsuzaki, M
Akai, T
Yamaguchi, M
Hayashi, S
Nishino, Y
Brautigam, M
Citation: F. Yabuuchi et al., Post-stroke treatment with imidapril reduces learning deficits with less formation of brain oedema in a stroke-prone substrain of spontaneously hypertensive rats, FUN CL PHAR, 13(4), 1999, pp. 475-483
Authors:
Uchimoto, R
Niwa, K
Eguchi, H
Kamiyama, N
Mine, Y
Miyazawa, T
Brautigam, M
Citation: R. Uchimoto et al., In vivo kinetics of microbubbles of SHU 508 A (Levovist((R))): Comparison with Indocyanine Green in rabbits, ULTRASOUN M, 25(9), 1999, pp. 1365-1370
Authors:
Kato, N
Takahashi, M
Tsuji, T
Ihara, S
Brautigam, M
Miyazawa, T
Citation: N. Kato et al., Dose-dependency and rate of decay of efficacy of Resovist on MR images in a rat cirrhotic liver model, INV RADIOL, 34(9), 1999, pp. 551-557
Authors:
Hamm, H
Schwinn, A
Brautigam, M
Weidinger, G
Citation: H. Hamm et al., Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species, BR J DERM, 140(3), 1999, pp. 480-482
Authors:
Schopf, RE
Hultsch, T
Lotz, J
Brautigam, M
Citation: Re. Schopf et al., Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A, J EUR A D V, 11(3), 1998, pp. 234-239
Authors:
Bai, LY
Yamaguchi, M
Tatsumi, M
Kon, K
Brautigam, M
Citation: Ly. Bai et al., Mechanisms responsible for resistance of sublines derived from leukemia cell lines to an antitumer agent 9-beta-D-arabinofuranosyl-2-fluoroadenine (vol 124, pg 367, 1998), J CANC RES, 124(11), 1998, pp. 641-641
Authors:
Mrowietz, U
Graeber, M
Brautigam, M
Thurston, M
Wagenaar, A
Weidinger, G
Christophers, E
Citation: U. Mrowietz et al., The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis whenused topically under occlusion, BR J DERM, 139(6), 1998, pp. 992-996